Methods of in vitro toxicology

Food and Chemical Toxicology

Volumn 40, Issue 2-3, 2002, Pages 193-236

  Eisenbrand, G ^a   Pool Zobel, B ^b   Baker, V ^c   Balls, M ^d   Blaauboer, B J ^e   Boobis, A ^f   Carere, A ^g   Kevekordes, S ^h   Lhuguenot, J C ⁱ   Pieters, R ^e   Kleiner, J ^j  

^a Rheinland Pfälzische Technische Universität Kaiserslautern Landau   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c UNILEVER RESEARCH   (United Kingdom)

^d JOINT RESEARCH CENTRE   (Italy)

^e UTRECHT UNIVERSITY   (Netherlands)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^h Sudzucker AG Mannheim/Ochsenfurt   (Germany)

ⁱ UNIVERSITÉ DE BOURGOGNE   (France)

^j International Life Sciences Institute of Europe   (Belgium)

more..

Author keywords

Biomarkers; Food chemicals; Hazard identification; In vitro methods; Parallelogram approach; Risk assessment

Indexed keywords

BIOLOGICAL MARKER; CARCINOGEN; CHEMICAL MUTAGEN; FOOD ADDITIVE; FOOD ALLERGEN; HEAT SHOCK PROTEIN; HORMONE DERIVATIVE; METALLOTHIONEIN; STRESS ACTIVATED PROTEIN KINASE; XENOBIOTIC AGENT;

ALLERGENICITY; ARTICLE; CHRONIC TOXICITY; CYTOTOXICITY; DNA ADDUCT; FOOD CONTAMINATION; FOOD PACKAGING; FOOD PROCESSING; GENOMICS; GENOTOXICITY; HAZARD ASSESSMENT; HUMAN; IN VITRO STUDY; MODEL; NONHUMAN; PREDICTION; PROTEOMICS; RISK ASSESSMENT; T LYMPHOCYTE; TOXICITY TESTING; TOXICOKINETICS;

EID: 18344391612     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-6915(01)00118-1     Document Type: Review

References (301)

1. Aneuploidy: A report of an ECETOC task force
2. Cytotoxicity of acetaminophen and papaverine in primary cultures of rat hepatocytes
3. Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation
4. Somatic cell mutations in cancer epidemiology
5. Adult stem cell plasticity and methods of detection
6. Animal cancer tests and cancer prevention
7. The causes and prevention of cancer: Gaining perspective
8. Physiologically based modelling of organic compounds
9. Chromosome aberrations, mitogen-induced blastogenesis and proliferative rate index in peripheral lymphocytes from 106 control individuals of the U.K. population
10. Effect of pretreatment with beta-naphthoflavone on tumorigenesis by N-nitrosoethylurea in five mouse strains
11. A comparison of selected mRNA and protein abundances in human liver
12. An assessment of human liver-derived in vitro systems to predict the in vivo metabolism and clearance of almokalant
13. Validation of an in vitro teratology system using chiral substances: Stereoselective teratogenicity of 4-yn-valproic acid in cultured mouse embryos
14. Alteration in protein synthesis in primary cultures of rat kidney proximal tubule epithelial cells by exposure to gallium, indium and arsenite
15. Detection of DNA-reactive metabolites in serum and their tissue distribution in mice exposed to multiple doses of carcinogen mixtures: Role in human biomonitoring
16. Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond
17. Correlation between oral drug absorption in humans an apparent drug permeability coefficeints in human intestinal epithelial (CACO-2) cells
18. The prospects for a simplified and internationally harmonized approach to the detection of possible human carcinogens and mutagens
19. Determination of the genotoxic status of a chemical
20. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S.NTP
21. Stability of food allergens to digestion in vitro
22. Population monitoring: Experience with residents exposed to uranium mining/milling waste
23. Absorption, distribution and metabolism of drugs
24. Report and recommendations of the CAAT/ERGATT workshop on the validation of toxicity test procedures
25. Practical aspects of the validation of toxicity test procedures. The report and recommendations of ECVAM workshop 5
26. The FRAME research program on in vitro toxicology
27. Further validation of FETAX: Evaluation of the developmental toxicity of five known mammalian teratogens and non-teratogens
28. Hazard identification by methods of animal-based toxicology
29. Quantitative structure-activity relationships (QSARs) for skin corrosivity of organic acids, bases and phenols: Principal components and neural network analysis of extended datasets
30. QSARs for the eye irritation potential of neutral organic chemicals
31. The use of in vitro cytotoxicity measurements for the prediction of the skin corrosivity potential of acids: A QSAR method
32. Evidence for the progressive nature of neoplastic transformation in vitro
33. Proliferation of human colonic mucosa as an intermediate biomarker of carcinogenesis: Effects of butyrate, desoxycholate, calcium, ammonia, and pH
34. The chemistry of contact allergy: Why is a molecule allergenic?
35. In vivo pharmacokinetics of felodipine predicted from in vitro studies in rat, dog and man
36. 32P-postlabeling assay
37. Biomakers as predictive tools in toxicity testing. The report and recommendations of ECVAM workshop 40
38. Relationship between in vitro mutagenicity assays
39. QSAR models for both mutagenic potency and activity: Application to nitroarenes and aromatic amines
40. Hepatic peroxisome proliferation in rodents and its significance for humans
41. The integrated use of alternative methods in toxicological risk evaluation. ECVAM integrated testing strategies task force report 1
42. An integrated approach to the prediction of the systemic toxicity using biokinetic models and biological in vitro test methods
43. The use of liver cell cultures derived from different mammalian species in in vitro toxicological studies: Implementation in extrapolation models?
44. Discordant expression of heat shock protein mRNA's in tussues of heat-stressed rats
45. Molecular evolution of the HSP70 multigene family
46. Comparisons of two in vitro cytotoxicity assays - The neutral red (NR) and tetrazolium MTT tests
47. In vitro cytotoxicity assays: Potential alternatives to the Draize ocular irritancy test
48. Toxicity determined in vitro by morphological alterations and neutral red absorption
49. How specific should immunological memory be?
50. The use of biomarkers as alternatives to current animal tests on food chemicals
51. Options available from start to finish for optaining expression data by microarray
52. Inhibition of tumor cell attachment to concanavalin A-coated surfaces as an assay for teratogenic agents: Approaches to validation
53. The current status for food additives toxicity testing and the potential for application of the Three Rs
54. Screening chemicals for reproductive toxicity: The current alternatives. The report and recommendations of an ECVAM/ECTS workshop (ECVAM Workshop 12)
55. Exploring the new world of the genome with DNA microarrays
56. Physiological parameter values for PBPK models
57. Genotoxicity of hexachlorbenzene and other chlorinated benzenes
58. Supervising the fold: Functional principles of molecular chaperones
59. A comprehensive approach to the integration of toxicity and cancer risk assessment
60. Chemically induced cell proliferation in carcinogenesis
61. Non-genotoxic carcinogens. Approaches to their risk assessment
62. Inflammatory and epithelial response during the development of ozone-induced mucous cell metaplasia in the nasal epithelium of rats
63. Comperative dermal carcinogenesis of shale and petrolium-derived distillates
64. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena
65. Cancer risk assessment at the crossroads: The need to turn to a biological approach
66. MEIC evaluation of acute systemic toxicity. Part VII. Prediction of human toxicity by results from testing of the first 30 reference chemicals with 27 further in vitro assays
67. A multiple dose-route physiological model for volatile chemicals using ACSL/PC
68. A physiologically based pharmacokinetic model for retinoic acid and its metabolites
69. Interrelationships between the gastrointestinal microflora and non-nutrient components of the diet
70. Effects of copper and tributyltin on stress protein abundance in the rotifer Brachionus plicatilis
71. Cell transformation assays as predictors of human carcinogenicity. The report and recommendations of ECVAM workshop 39
72. Human somatic mutation assays as biomarkers of carcinogenesis
73. The use of heterologously expressed drug metabolizing enzymes - State of the art and prospects for the future
74. Multivariate analysis of a skin sensitization database
75. Molecular modeling of mammalian cytochrome P450s
76. Chick embryo retinal cell cultures as a screen for developmental toxicity
77. The isolated blood perfused pig ear: An inexpensive and animal-saving model for skin penetration studies
78. Stress protein synthesis in human keratinocytes treated with sodium arsentie, phenyldichloroarsine and nitrogen mustard
79. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity
80. An integrated approach to the prediction of systemic toxicity using computer-based biokinetic models and biological in vitro test methode: Overview of a prevalidation study based on the ECITTS project
81. Estimation of systemic toxicity of acrylamide by integration of in vitro toxicity data with kinetic simulations
82. A quantitative property-property relationship (QPPR) approach to estimate in vitro tissue-blood partition coefficients of organic chemicals in rats and humans
83. Role of kinetics in acute lethality of nonreactive volatile organic compounds (VOCs)
84. Use of cDNA microarray to analys gene expression patterns in human cancer
85. Challenge for the successful prediction of drug metabolism in vivo from studies in vitro: Simulation of variability
86. Cytotoxicity testing of 114 compounds by the determination of the protein content in HepG2 cell cultures
87. The use of liver spheriods as an in vitro model for studying inductions of the stress response as a marker for chemical toxicity
88. An investigation into the sensitivity of heat shock proteins as markers of cellular damage: A comparative study of hydrazine and cadmium chloride in primary rat heoatocyte cultures
89. Effects of a low-fat diet on levels of oxidative damage to DNA in human peripheral nucleated blood cells
90. Oxidative injury and the heat shock response
91. Expression profiling using cDNA microarrays
92. The influence of cell growth, detoxifying enzymes and DNA repair on hydrogen peroxide-mediated DNA damage (measured using the comet assay) in human cells
93. Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes
94. Hazard characterisation of chemicals in food and diet: Dose-response, mechanisms, and extrapolation issues
95. MethyLight: A high-throughput assay to meassure DNA methylation
96. Mathematical modeling and quantitative methods
97. Cluster analysis and display of genome-wide expression patters
98. Cell proliferation indexes: A biomarker in solid tumors
99. Determination of DNA adducts of malonaldehyde in humans: Effects of dietary fatty acid composition
100. The role of calcium in lethal cell injury
101. Reactive oxygen species in tumorigenesis
102. A comparison of lymphocyte micronuclei and plasma micronutrients in vegetarians and non-vegetarians
103. Moderate wine consumption protects against hydrogen peroxide-induced DNA damage
104. Rapid liquid Chromatography with tandem mass spectrometry-based screening procedures for studies on the biotransformation of drug candidates
105. Determination and prediction of tissue-gas partition coefficients
106. In vitro tests for teratogens: Desirable endpoints, test batteries and current status of me micromass teratogen test
107. Primary cultures of brain microvessel endithelial cells: A valid and flexible model to study drug transport through the blood-brain barrier in vitro
108. In vitro skin permeation techniques
109. Prevalence of intolerance to food additives among Danish school children
110. Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues
111. Modeling the tissue solubilities and metabolic rate constant (Vmax) of halogenated methanes, ethanes and ethylenes
112. The utilization of rabbit alveolar macrophage and Chinese hamster ovary cells for evaluation of the toxicity of particulate materials
113. Physiologycally based pharmacokinetic and pharmacodynamic model for the inhibition of acetylcholinesterase by diisopropylfluorophosphate
114. Development of prediction models for three in vitro embryotoxicity tests in an ECVAM validation study
115. Detection of aneuploidy-inducing carcinogens in the Syrian hamster embryo (SHE) cell transformation assay
116. Effects of colonic luminal components on AP-1 dependent gene transcription in cultured human colon carcinoma cells
117. Genotoxicity testing of biotechnology-derived products. Report of a GUM task force
118. Phagocytes render chemicals immunogenic: Oxidation of gold(I) to the T cell-sensitizing gold(III) metabolite generated by mononuclear phagocytes
119. Stress protein synthesis induced in rat liver by cadmium precedes hepatotoxicity
120. Heat shock proteins as markers of neural injury
121. Powerful tools for genetic analysis come of age
122. Alteration of a model antigen by Au(III) leads to T cell sensitization to cryptic peptides
123. The role of oxidative stress in diseases caused by mineral dusts and fibres: Current status and future of prophylaxis and treatment
124. Use of a flow cell bioreactor as a chronic toxicity model system
125. Phenytoin-induced stress protein synthesis in mouse embryonic tissue
126. 2u-globulin, hyaline droplet nephropathy, and tubule neoplasia in the kidney of male rats
127. An evaluation of the role of calcium in cell injury
128. The standardisation of cell culture practices
129. New methods for detection of low levels of DNA damage in human populations
130. The perturbation of apoptosis and mitosis by drugs and xenobiotics
131. Activation and expansion of hapten- and protein-specific T helper cells from nonsensitized mice
132. Overview of genotoxic carcinogens and non-genotoxic carcinogens
133. Mutagenicity of human urine caused by ingestion of fried ground beef
134. Real time quantitative PCR
135. Calnexin, calreticulin and the folding of glycoproteins
136. Toward the primary prevention of cancer
137. Hydrolysis of low-molecular-weight oligosaccharides and oligosaccaride alditols by pig intestinal/isomaltase and glucosidase/maltase
138. An in vitro embryotoxicity assay using the differentiation of embryonic mouse stem cells into haematopoietic cells
139. Prediction of in vivo kinetic constants from kinetic constants measured in vitro
140. Cyclosporine induces cancer progression by a cellautonomous mechanism
141. Quantitative methods for measuring the cell growth and death
142. Inhibition of the activation of heat shock factor in vivo and in vitro by flavonoids
143. Prediction of hepatic clearance from microsomes, hepatocytes and liver slices
144. Polychlorinated dibenzo-para-dioxins
145. Short- and medium-term carcinogenicity tests, mutation analysis, and multistage models in risk identification
146. Quantitative prediction of in vivo drug clearance and drug interactions from in vitro data on metabolism, together with binding and transport
147. Effects of intesinal CYP3A4 and P-glycoprotein on oral drug absorption - Theoretical approach
148. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis
149. The chick embryotoxicity screening test (CHEST)
150. Chick embryotoxicity screening test-130 substances tested
151. The restriction site mutation assay: A review of the methodology development and the current status of the technique
152. A partition coefficient determination method for nonvolatile chemicals in biological tissues
153. Skin penetration and metabolism of topically applied chemicalss in six mammalian species, including man: An in vitro study with benzo(a)pyrene and testosterone
154. Comparison of three different in vitro mutation assays used for the investigation of cytochrome P450-mediated mutagenicity of nitro-polycyclic aromatic hydrocarbons
155. The gastrin hypothesis. Implications for antisecretory drug selection
156. Calcium signalling and cytotoxicity
157. Stress signalling from the lumen of the endoplasmic reticulum: Coordination of gene transcriptional and translational controls
158. Kinetic analysis of furan biotransformation by F-344 rats in vivo and in vitro
159. Nutrition chemoprevention of gastrointestinal cancers: A critical review
160. Induction of metallothionein as an adaptive mechanism affecting the magnitude and progreeion of toxicological injury
161. The role of oxidative stress in chemical carcinogenesis
162. DNA methylation, heterochromatin and epigenetic carcinogens
163. Commentary: Oncogene activation and tumor suppression
164. Carrier-independent hapten recognition and promiscuous MHC restriction by CD4 T cells induced by trinitrophenylated peptides
165. Identification and characterization of genes associated with human hepatocellular carcinogenesis
166. Development of an automated mass spectrometry system for the quantitative analysis of liver microsomal incubation samples: A tool for rapid screening of new compounds for metabolic stability
167. Genetic toxicology
168. Threshold of toxicological concern for chemical substances present in the diet: A practical tool for assessing the need for toxicity testing
169. Assessment of intake from the diet
170. Validation of whole chick embryo cultures, whole rat embryo cultures and aggregating embryonic brain cell cultures using six pairs of coded compounds
171. Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations
172. Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes
173. Mammalian stress response: Inductions of the glucose-regulated protein family
174. Human intestinal permeability
175. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction
176. Significance of multiple mutations in cancer
177. A cell culture assay for the detection of cardiotoxicity
178. Critical assessment of the epidemiological data concerning the impact of antioxidant nutrients on cancer and cardiovascular disease
179. Microsatellite alterations as clonal markers for the detection of human cancer
180. Inhibition of cytochrome P-450p (P450IIIA1) gene expression during liver regeneration from two-thirds hepatectomy in the rat
181. Apoptosis and chemical carcinogenesis
182. The role of reactive oxygen and nitrogen species in the response of airway epithelium to particulates
183. Effect of human faecal donor on in vitro fermentation variables
184. The significance of hepatic microsomal enzyme induction and altered thyroid function in rats: Implications for thyroid gland neoplasia
185. The role of calcium in the regulation of apoptosis
186. Mechanism of respiratory tissue injury from cigarette smoking
187. Dermal absorption of organic chemical vapours in rats and humans
188. An IARC evaluation of polychlorinated dibenzo-p-dioxins and polychloinated dibenzofurans as risk factors in human carcinogenesis
189. Human lymphocyte heme oxygenase 1 as a response biomarker to inorganic arsenic
190. Assessment of the allergenic potential of foods derived from genetically engineered crop plants
191. Environmental factors as regulators and effectors of multistep carcinogenesis
192. ICH-harmonised guidances on genotoxicity testing of pharmaceuticals: Evolution, reasoning and impact
193. A short term screening test for teratogens using differentiating neuroblastoma cells in vitro
194. 8-Hydroxydeoxyguanosine in human leukocyte DNA and daily health practice factors: Effects of individual alcohol sensitivity
195. Pharmacokinetic aspects of in vitro teratogenicity studies: Comparison to in vivo
196. Epigenetic events during the process of cell transformation induced by carcinogens
197. 2+ in cell killing
198. Plasma malondialdehyde as biomarker for oxidative stress: Reference interval and effects of life-style factors
199. Effects of trypan blue on rat and rabbit embryos cultured in vitro
200. New screening methods for chemicals with hormonal activities using interaction of nuclear hormone receptor with coactivator
201. Evaluation of an in vitro cell toxicity using rabbit corneal cells to predict the eye-irritation potential of surfactants
202. Microarrays and toxicology: The advent of toxicogenomics
203. High resolution two-dimensional electrophoresis of proteins
204. The prediction of human pharmacokinetic parameters from preclinical and in vitro meatbolism data
205. Mutagen hypersensitivity as a biomarker of genetic predisposition to carcinogenesis
206. Introducing chemists to food allergy
207. Methods of determining plasma and tissue binding of drugs
208. Antigen-dependent and-independent IFN-gamma modulation by penicillins
209. Phases of biomarker development for early detection of cancer
210. Partition Coefficients of some industrial aliphatic hydrocarbons (C5-C7) in blood and human tissues
211. Molecular epidemiology: Insights into cancer susceptibility, risk assessment, and prevention
212. Biomarkers and molecular epidemiology in mutation/cancer research
213. Novel in vitro methods for long-term toxicity testing
214. Interlaboratory evaluation of embryotoxicity in the postimplantation rat embryo culture
215. Comparative immunochemical and structural similarities of five stress proteins from various tissue types
216. The molecular biology of carcinogenesis
217. Consumption of vegetables reduces genetic damage in humans: First results of an intervention trial with carotenoid-rich foods
218. Induction of DNA damage in human colon cells derived from biopsies by suggested risk factors of colon cancer
219. Detection of genotoxic effects in human gastric and nasal mucosa cells isolated from biopsy samples
220. Prescreening for environmental teratogens using cultured mesenchymal cells from the human embryonic palate
221. Increased cell division as a cause of human cancer
222. Review of the current status of calcium and thiols in cellular injury
223. Phylogenetic analysis of the stress-70 protein family
224. Carcinogenity of captan
225. Diets high in fat and meat, but low in fiber increase the genotoxic potential of fecal water
226. The derivation of quantitative correlations between skin sensitisation and physiko-chemical parameters for alkylating agents, and their application to experimental data for sultones
227. Application of DNA arrays to toxicology
228. A brief history of the use of laboratory animals for the prediction of carcinogenic risk for man with a note on needs for the future
229. Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: Developmentally regulated expression of myogenic determination genes and functional expression of ionic currents
230. Pharmacogenetics and the practice of medicine
231. In vivo and in vitro models of the human colonic flora
232. Crossreactivity patterns of contact-sensitizing methacrylates
233. Human T lymphocyte priming in vitro by haptenated autologous dendritic cells
234. Whole embryo culture: A screening technique for teratogens?
235. A structure-activity relationship of some chlorinated hydrocarbons
236. Quantitative monitoring of gene-expression patterns with a complementary DNA microarray
237. Teratogenicity testing of new drugs with the postimplantation embryo culture system
238. DNA adducts in humans as dosimeters of exposture to environmental, occupational, or dietary genotoxins
239. First principles investigation of singly reduced cytochrome P450
240. Acute toxicity testing in vitro and the classification and labelling of chemivals. The report and recommendations of ECVAM workshop 16
241. Quantitative structure-pharmacokinetic relationships and drug design
242. Reactive oxygen species and silica-induced carcinogenesis
243. Uridine uptake inhibition as a cytotoxicity test: Correlations with the draize test
244. Evaluating the mutagenic potential of chemicals. The minimal battery and extrapolation problems
245. Reproduction and development
246. EU/COLIPA "In vitro phototoxicity" validation study, results of phase II (blind trial), part 1: The 3T3 NRU phototoxicity test
247. Lessons learned from validation of in vitro toxicity test: From failture to acceptence into regulatory practice
248. The embryonic stem cell test (EST): An in vitro embryotoxicity test using two permanent mouse cell lines
249. Unique role of studies on preimplantation embryos to understand mechanisms of embryotoxicity in early pregnancy
250. Evaluation of two in vitro assays to screen for potential development toxicants
251. The lymphocyte transformation test for diagnosis of drug-induced occupational allergy
252. Human hepatocyte-mediated mutagenesis and DNA repair activity
253. Cytotoxic effects on the plasma membrane of human diploid fibroblasts, a comparative study of leakage tests
254. PBPK modeling/Monte Carlo simulation of methylene chloride kinetic changes in mice in relation to age and acute, subchronic, and chronic inhalation exposure
255. Rat lung and liver microsomal cytochrome P450 isoenzymes involved in the hydroxylation of n-hexane
256. Calcium-mediated cell injury and cell death
257. Cytogenetic end-points as biological dosimeters and predictors of risk in epidemiological studies
258. The effect of cell population density on the developmental fate of reaggregating mouse limb bud mesenchyme
259. Mechanisms of carcinogenesis in risk identification
260. Uridine uptake inhibition as a cytotoxicity test for a human hepatoma cell line (HepG2 cells): Comparison with the neutral red assay
261. The contribution of epidemiology
262. Serial analysis of gene expression
263. Genotoxic activity in human faecal water and the role of bile acids: A study using the alkaline comet assay
264. Improved mass accuracy in matrix-assisted laser desorption/ionization time-of-flight mass-spectrometry of peptides
265. DNA methylation and the association between genetic and epigenetic changes: Relation to carcinogenesis
266. The application of in vitro data in the derivation of the acceptable daily intake of food additives
267. ECITTS: An integrated approach to the application of in vitro test systems to the hazard assessment of chemicals
268. Technology for microarray analysis of gene expression
269. P450 gene induction by structurally diverse xenochemicals: Central role of nuclear receptors CAR, PXR, and PPAR
270. Neutral red assay of the cytotoxicity of fluorocarbon coated polymethylmethacrylate intraocular lenses in vitro
271. Reproductive actions of phytoestrogens
272. Carcinogen-DNA and carcinogen-protein adducts in molecular epidemiology
273. Epigenetic carcinogens: Evaluation and risk assessment
274. A double-blind assessment of additive intolerance in children using a 12 day challenge period at home
275. Comparison of cytochrome P450 isoenzyme profiles in rat liver and hepatocyte cultures
276. Geographic association between urinary excretion of N-nitroso compounds and oesophageal cancer mortality in China
277. Mutational spectra of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) at the chinese hamster hprt locus
278. Nongenotoxic carcinogens: Development of detection methods based on mechanisms: A European project
279. Pharmacokinetics
280. Approaches to developing alternative and predictive toxicology based on PBPK/PD and QSAR modeling
281. Experimental study for the development of an in vitro test for contact allergens. 1. Primary activation of hapten-specific T cells by hapten-conjugated epidermal cells
282. Strategies and philosophies of genotoxicity testing. What is the question?
283. High-density cDNA filter analysis: A novel approach for large-scale, quantitative analysis of gene expression
284. Cap43, a novel gene specifically induced by Ni2+ compounds